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Competitive and standard enzyme-linked immunosorbent assays (ELISAs), rose bengal (RB), complement
fixation, and agar gel immunoprecipitation with native hapten (AGID-NH) were compared by using sera from
Brucella-free, Brucella melitensis-infected, and B. melitensis Rev1-vaccinated sheep. The most sensitive tests were
indirect ELISA and RB, and the most specific tests were AGID-NH and competitive ELISA. We show that RB
followed by AGID-NH is a simple and effective system for diagnosing sheep brucellosis.
Sheep brucellosis is a zoonotic disease that causes human
suffering and great economic losses. When implemented, the
control of this disease is usually based on vaccination, serolog-
ical testing, and culling. Until now, the best vaccine available
has been the smooth (S) Brucella melitensis Rev1 strain. Al-
though this strain is useful, it does not afford 100% protection,
and it induces a strong antibody response to the S lipopolysac-
charide (S-LPS), particularly when used in adult sheep. Since
S-LPS is the most relevant antigen in conventional serological
tests such as the rose bengal (RB) and the complement fixation
(CF) assays (3), it is not surprising that Rev1 vaccination in-
terferes with serological diagnosis. Vaccination of young sheep
(rather than adult sheep) by the conjunctival route (rather than
subcutaneously) reduces the antibody response without signif-
icantly affecting the protection levels; even so, conventional
serological diagnosis requires the use of screening and confir-
matory tests such as RB and CF, respectively. However, the
use of these two tests does not result in 100% sensitivity and
specificity (6, 7, 17).
To reduce these restrictions in the use of the vaccine and to
facilitate serological diagnosis, alternative assays have been
investigated, including tests that detect antibodies to proteins
(8, 9, 16, 18, 25) and to the S-LPS-related native hapten (NH)
polysaccharide (5, 12, 13, 17). Moreover, indirect enzyme-
linked immunosorbent assays (iELISAs) with S-LPS have been
investigated, but when adjusted to optimal sensitivity, they lack
specificity for sera from vaccinated sheep (7, 17). Similar prob-
lems are encountered in the diagnosis of cattle brucellosis
when vaccination with Brucella abortus 19 is implemented, so
to improve the specificity of the iELISAs under these condi-
tions, a competitive ELISA (cELISA) was developed (14, 15,
21, 22). This cELISA is based on the displacement of serum
antibodies by a fixed concentration of a mouse monoclonal
antibody (MAb) against the common (C/Y) epitope, which is
the dominant epitope in the O polysaccharides of both B.
abortus and B. melitensis and is the most relevant in serological
diagnosis. Since the cELISA does not involve the use of a
specific conjugate anti-animal species immunoglobulin, this as-
say can be easily adapted to detect Brucella infections in dif-
ferent animal species. The aim of our work was to compare this
cELISA, the iELISA, an immunoprecipitation assay with NH,
and the standard tests.
Blood sera were obtained from sheep naturally infected with
B. melitensis (29 with biotype 1 and 26 with biotype 3, as
demonstrated by bacteriological cultures of necropsy samples
[7, 19]) and from 60 sheep belonging to Brucella-free flocks.
Sera were tested by the cELISA system supplied by the Joint
FAO/IAEA Division of the International Atomic Energy
Agency (Vienna, Austria), which was shipped as a kit with the
necessary protocols and computation analysis procedures. The
kit contained 96-well polystyrene plates, standardized B. abor-
tus biotype 1 S-LPS phenol-water extract (24), mouse MAb
M84 of C/Y specificity, horseradish peroxidase-conjugated
goat anti-mouse immunoglobulin G (heavy plus light chain
specificity), 2,29-azinobis(3-ethylbenzthiazolinesulfonic acid)
(ABTS) diammonium salt substrate, buffer substances, and
negative and positive (strongly, intermediately, and weakly)
bovine sera as controls (15). To adapt the cELISA for testing
sheep sera, these controls were replaced by pools of sera from
Brucella-free or B. melitensis-infected sheep (see above), and
the dilutions of the positive pools were adjusted to yield optical
densities equivalent to the strongly, intermediately, and weakly
positive bovine controls. The assay was carried out as described
in previous works (14, 15, 22), and the results were expressed
as the percent inhibition of binding of MAb M84 {[(1 2 mean
absorbance value of the duplicate test sample)/mean absor-
bance value of triplicate test with the MAb alone] 3 100}. The
iELISA was performed with a crude B. melitensis S-LPS prep-
aration (1, 4, 11, 17) and peroxidase-conjugated protein G, and
the results were expressed as the percentage of the optical
density with respect to a strongly positive control serum (1, 13,
17). The agar gel immunodiffusion test for detecting NH-pre-
cipitating antibodies (AGID-NH) was performed with 1% No-
ble agar (Difco Laboratories, Detroit, Mich.) gels in 10%
NaCl–0.1 M NaOH-H3BO4 (pH 8.3) with 20 ml of serum and
the antigen wells set 3 mm apart. The antigen was an NH-rich
B. melitensis 16M hot-water extract in which the NH precipi-
tation band is characteristic (4, 10, 11, 20). The CF (3) and RB
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tests were also used, the latter with a 3:1 proportion of serum
to antigen for optimal sensitivity (6).
Receiver-operating characteristic analyses (SAS statistical
package version 6 [SAS Institute Inc.]) of the results obtained
by the iELISAs and cELISAs of the sera from the B. melitensis-
infected and Brucella-free sheep showed that both assays
yielded optimal sensitivity and specificity with the 1:50 serum
dilution. Moreover, the results of each type of ELISA show
that the distributions of the sera from sheep infected with B.
melitensis biotype 1 and biotype 3 were similar (not shown),
thus confirming that the S-LPS ELISAs for animal brucellosis
perform similarly regardless of the antigen source (i.e., B.
abortus or B. melitensis) and regardless of the infecting Brucella
species or biotype (1). For the 1:50 serum dilution, the distri-
bution of the absorbance values of the cELISAs (Fig. 1A)
showed that binding of MAb M84 was less than 20% inhibited
by the 60 sera from Brucella-free sheep and that all but 2 sera
from B. melitensis-infected sheep inhibited MAb M84 binding
by more than 20%. Thus, with the 20% cutoff, the sensitivity
(percentage of truly infected animals identified as positive) and
specificity (percentage of truly uninfected animals identified as
negative) of the cELISA were 96 and 100%, respectively. With
these sera, the iELISA (Fig. 1B) completely discriminated the
sera from the Brucella-free and B. melitensis-infected popula-
tions (100% sensitivity and specificity), even though the differ-
ence in sensitivity from cELISA was not statistically significant
(P 5 0.15, two-tailed Student’s t test). As demonstrated for the
iELISA, the RB test showed 100% sensitivity, and both tests
were more sensitive (P , 0.05) than the CF (92%) and
AGID-NH (90%) tests. The sensitivities of the CF and
AGID-NH tests were similar to each other (P 5 0.73) and
were not significantly different from that of the cELISA (P 5
0.40 and P 5 0.24, respectively). The AGID-NH, RB, and CF
tests showed 100% specificities for sera from Brucella-free
animals.
The specificities of these tests in the context of a vaccination
program were studied by using sera of two groups of lambs plus
two groups of adult sheep (all from Brucella-free flocks) that
had been vaccinated either subcutaneously or conjunctivally
with 109 CFU of B. melitensis Rev1 and maintained in a Bru-
cella-free environment. For the purpose of this study, the an-
imals were bled at different time intervals (Table 1), although
only the last bleedings represented a situation similar to that
found in ordinary eradication programs. The specificities of the
tests (i.e., the percentage of vaccinated animals that tested
negative and, therefore, would not be misdiagnosed as in-
fected) varied depending upon the age of the animal and the
route of vaccination (Table 1). As expected (17), the specific-
ities of all tests were generally higher when the sera of con-
junctivally vaccinated sheep and the sera of lambs were tested.
The results also showed that the specificity of the cELISA was
constantly higher than that of the iELISA, with very marked
differences in the group of subcutaneously vaccinated lambs
and, no matter which route of vaccination, in the vaccinated
adult sheep. The specificity values in this last group were in-
dependent from the vaccination route. The cELISA and
AGID-NH test were more specific. Although the differences
were not statistically significant, the AGID-NH test seemed to
perform better than cELISA only when the sera of adult sheep
bled 5 months after subcutaneous vaccination were tested. The
tests had similar specificities. The CF test, which is the stan-
dard confirmatory test (3, 6), showed higher specificity than the
cELISA in only two of the bleedings of the conjunctivally
vaccinated lambs.
It is noteworthy that a relatively simple test such as the
AGID-NH test was as specific as the sophisticated cELISA. As
demonstrated by the contrasting results of iELISA and
cELISA, the diagnostic specificity of the latter is due to the
elimination of low-affinity antibodies (dominant in the sera of
vaccinated animals) by the competing anti-C/Y MAb. Anti-
body affinity, rather than epitopic differences between S-LPS
and NH, is also likely to account in part for the performance of
the AGID-NH test (2).
Immunochemical studies have shown that the NH and the O
polysaccharide of the S-LPS (which is the serologically relevant
section of S-LPS) have similar structures and epitopic densities
(4, 12). In fact, antibodies to the NH can be absorbed with
S-LPS (2). However, precipitation tests with S-LPS do not
show the sensitivity and specificity of similar tests performed
with NH (10, 11, 20), although NH and S-LPS yield similar
results in both iELISA (1, 2, 13) and passive hemagglutination
(2). To explain these apparently contradictory observations, we
have proposed (2) that the higher specificities of the precipi-
tation tests with NH result from two sets of factors. First, the
dispersed state of the low-molecular-weight NH (4) in solution,
as opposed to the highly aggregated S-LPSs, may be relevant in
explaining their different behavior in precipitation tests. Sec-
ond, if low-affinity antibodies are predominant after vaccina-
tion, the higher threshold affinity of precipitation tests com-
FIG. 1. Distribution of the sera of B. melitensis-infected (black bars) and
Brucella-free (open bars) sheep according to the results of the cELISA (A) and
the iELISA (B).
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pared to that of iELISAs (23) may explain why NH fails to
react with sera from vaccinated animals in the former but not
in the latter assay. Obviously, the comparison of the results of
the i and cELISAs demonstrates that the sera of vaccinated
sheep contain more antibodies of lower affinity than do sera
from infected sheep, and this is consistent with the proposed
hypothesis.
The results of this work have practical implications concern-
ing the use of the tests evaluated. In the absence of vaccination,
the iELISA and the much less sophisticated RB test (standard-
ized and performed as described in reference 6) should be the
tests of choice because of their very high sensitivities. When
vaccination was implemented, no single test simultaneously
afforded 100% sensitivity and specificity. Although the cELISA
greatly improves the specificity of the iELISA, the data suggest
that it is less sensitive. Therefore, the study of larger numbers
of sera from bacteriologically positive animals is necessary
before the use of the cELISA can be recommended as a single
diagnostic test for B. melitensis sheep brucellosis. However,
screening with either the iELISA or the RB assay followed by
confirmation by means of either the cELISA or the AGID-NH
test would afford the best combination of sensitivity and spec-
ificity. Both ELISAs are technically more demanding, and
since they do not outperform the unsophisticated RB and
AGID-NH tests, the latter seem to be the simplest choice for
the diagnosis of sheep brucellosis when Rev1 vaccination is
implemented.
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timeb No. of sheep
% Specificity of:
RB test CF AGID-NHtest iELISA cELISA
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